Aditus Laboratories Limited
About Aditus Laboratories Limited
Data last updated:
Aditus Laboratories Limited is a public limited company based in Hyderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 27 November 2003 and has been in existence for over 23 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2003PLC042139. Its GSTIN is 36AAECA7543H1ZN (Telangana).
The company has an authorised share capital of ₹3 Cr and a paid-up capital of ₹3 Cr. It is led by directors including Dharma Reddy Bakka and Harish Kumar Reddy Vakiti.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.64 Cr, a growth of 112% compared to the previous year. For the same year it recorded a net profit of ₹1.99 Lakh (net margin 0.8%) and EBITDA of ₹83.55 Lakh (EBITDA margin 31.7%). Revenue has grown at a compounded annual rate (CAGR) of 14% over three years and 9% over five years.
As per MCA filings, the company has open charges of ₹5.42 Cr and satisfied charges of ₹1.19 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressGround Floor Plot No 25(B) Survey No 35, Phase – I Ida Cherlapally Medchal Malkajgiri, Hyderabad, Telangana, India – 500051
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Aditus Laboratories Limited
The main business activity of Aditus Laboratories is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Aditus Laboratories Limited FY 2025 filings available
Aditus Laboratories Limited reported revenue of ₹2.64 Cr (up 112% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Aditus Laboratories Limited
Revenue has grown at a compounded annual rate (CAGR) of 9% over five years, including 112% growth in the latest year. EBITDA rose 330% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Aditus Laboratories Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹83.55 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.99 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Aditus Laboratories Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 31.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Aditus Laboratories are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Aditus Laboratories Limited
Aditus Laboratories has 3 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dharma Reddy Bakka | Additional Director | 07 Jan 2026 | 0 Years 9 Months | Current |
| Harish Kumar Reddy Vakiti Also directs: S D Life Sciences India Private Limited | Additional Director | 30 Aug 2023 | 3 Years 1 Months | Current |
| Bakka Ashwini | Additional Director | 30 Aug 2023 | 3 Years 1 Months | Current |
Peer Comparison of Aditus Laboratories Limited
Aditus Laboratories Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Neovant Therapeutics Private Limited | ₹2.66 Cr (FY 2025) | •••• | •••• | -71.0% | •••• | Mehsana, Gujarat, India |
| Chethana Medicaments Pvt Ltd | ₹2.65 Cr (FY 2025) | •••• | •••• | 11.0% | •••• | Malappuram, Kerala, India |
| QXP Pharma Project and GMP Services Private Limited | ₹2.65 Cr (FY 2025) | •••• | •••• | 190.0% | •••• | Sanand, Gujarat, India |
| Barrhgarh Hydro Power Project Private Limited | ₹2.65 Cr (FY 2025) | •••• | •••• | 104.0% | •••• | Himachal Pradesh, India |
| Gleveztar Lifesciences Private Limited | ₹2.64 Cr (FY 2025) | •••• | •••• | 504.0% | •••• | Gurgaon, Haryana, India |
| Aditus Laboratories Limited this company | ₹2.64 Cr (FY 2025) | •••• | •••• | 112.0% | •••• | Hyderabad, Telangana, India |
| Timetech Pharma Private Limited | ₹2.64 Cr (FY 2025) | •••• | •••• | -3.0% | •••• | New Delhi, Delhi, India |
| Nark Pharmaceuticals Private Limited | ₹2.64 Cr (FY 2025) | •••• | •••• | 3.0% | •••• | Ernakulam, Kerala, India |
| Metabolica Lifecare Private Limited | ₹2.63 Cr (FY 2025) | •••• | •••• | 13.0% | •••• | Pune, Maharashtra, India |
| Bee Lifecare Private Limited | ₹2.62 Cr (FY 2018) | •••• | •••• | -11.0% | •••• | Chandigarh, India |
| Ingram Biosciences Private Limited | ₹2.62 Cr (FY 2024) | •••• | •••• | 115.0% | •••• | Noida, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Aditus Laboratories by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Charges & Borrowings of Aditus Laboratories Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Dec 2023 | State Bank of India | ₹5.42 Cr | Open |
| 25 Feb 2020 | State Bank of India | ₹36 Lakh | Satisfied |
| 22 Jan 2013 | State Bank of India | ₹4 Lakh | Satisfied |
| 21 Sep 2010 | State Bank of India | ₹48.16 Lakh | Satisfied |
| 25 Feb 2006 | State Bank of India | ₹21.8 Lakh | Satisfied |
Total charge records: 6 View all charges
Employees and EPFO Compliance at Aditus Laboratories Limited
Employment history and EPFO contributions of people linked to Aditus Laboratories.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Aditus Laboratories Limited
Aditus Laboratories Limited has 10 board changes on record since 2022: 4 appointments and 6 cessations. The latest: Dharma Reddy Bakka was appointed as Additional Director on 07 Jan 2026.
12 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Aditus Laboratories Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Aditus Laboratories Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Aditus Laboratories Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Aditus Laboratories Limited
Aditus Laboratories has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAECA7543H1ZN | Telangana | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Aditus Laboratories Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aditus Laboratories Limited
Aditus Laboratories is an active public limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 27 November 2003 (23+ years old) and is registered under CIN U24239TG2003PLC042139.
Aditus Laboratories reported revenue of ₹2.64 Cr for FY 2025 (up 112% YoY).
Aditus Laboratories has 3 current directors:
- Dharma Reddy Bakka - Additional Director
- Harish Kumar Reddy Vakiti - Additional Director
- Bakka Ashwini - Additional Director
Aditus Laboratories reported a net profit of ₹1.99 Lakh (net margin 0.8%) and EBITDA of ₹83.55 Lakh (EBITDA margin 31.7%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Aditus Laboratories is 14% over three years and 9% over five years. In the latest year (FY 2025) revenue rose 112%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Aditus Laboratories is 36AAECA7543H1ZN, registered in Telangana.
The CIN (Corporate Identification Number) of Aditus Laboratories is U24239TG2003PLC042139. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aditus Laboratories was incorporated on 27 November 2003, making it 23+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Aditus Laboratories by revenue are Neovant Therapeutics Private Limited, Chethana Medicaments Pvt Ltd, QXP Pharma Project and GMP Services Private Limited, Barrhgarh Hydro Power Project Private Limited, Gleveztar Lifesciences Private Limited and 5 more, all in the Pharma industry (Formulations).
Dharma Reddy Bakka was appointed as Additional Director on 07 Jan 2026. Balamani Vakiti ceased to be Additional Director on 19 Mar 2025. Suresh Reddy Vakiti ceased to be Additional Director on 19 Mar 2025. Aditus Laboratories has 10 board changes on record in total.
The registered office of Aditus Laboratories is at Ground Floor Plot No 25B Survey No 35, Phase – I Ida Cherlapally Medchal Malkajgiri, Hyderabad, Telangana, India – 500051.